Institutional Ownership Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO). We have compiled data on the 664 institutions that hold shares in the stock, with a total of 128 Million shares, which have been reported (via 13F filing form) to have a value of $8.95 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Epoch Investment Partners, Inc.
New York, NY |
Nov 13, 2025 Q3 2025 |
596,606
shares
|
$41.8 Million
0.25% of portfolio
|
Q3 2025
Reduced 5.58%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2025 Q3 2025 |
585,660
shares
|
$41 Million
0.01% of portfolio
|
Q3 2025
Reduced 15.39%
|
|
|
Citigroup Inc
|
Nov 10, 2025 Q3 2025 |
549,891
shares
|
$38.5 Million
0.02% of portfolio
|
Q3 2025
Added 45.66%
|
|
|
Glenmede Trust CO Na
Philadelphia, PA |
May 15, 2025 Q1 2025 |
499,029
shares
|
$34.9 Million
0.18% of portfolio
|
Q1 2025
Added 3.12%
|
|
|
Ray Dalio
Bridgewater Associates, LP | Westport, Ct
|
Nov 13, 2025 Q3 2025 |
487,081
shares
|
$34.1 Million
0.15% of portfolio
|
Q3 2025
New holding
|
|
|
Pacer Advisors, Inc.
Malvern, PA |
Oct 15, 2025 Q3 2025 |
478,874
shares
|
$33.5 Million
0.1% of portfolio
|
Q3 2025
Added 2054.66%
|
|
|
Renaissance Group LLC
Covington, KY |
Nov 05, 2025 Q3 2025 |
478,735
shares
|
$33.5 Million
1.37% of portfolio
|
Q3 2025
New holding
|
|
|
Empowered Funds, LLC
|
Nov 13, 2025 Q3 2025 |
471,124
shares
|
$33 Million
0.37% of portfolio
|
Q3 2025
Added 0.97%
|
|
|
Sei Investments CO
Oaks, PA |
Nov 13, 2025 Q3 2025 |
460,992
shares
|
$32.3 Million
0.04% of portfolio
|
Q3 2025
Added 12.06%
|
|
|
Boston Partners
Boston, MA |
Nov 13, 2025 Q3 2025 |
444,803
shares
|
$31.1 Million
0.04% of portfolio
|
Q3 2025
Reduced 1.02%
|
|
|
Bank Of Montreal
Toronto, A6 |
Nov 13, 2025 Q3 2025 |
415,616
shares
|
$29.1 Million
0.01% of portfolio
|
Q3 2025
Reduced 15.94%
|
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Nov 12, 2025 Q3 2025 |
410,892
shares
|
$28.8 Million
0.01% of portfolio
|
Q3 2025
Added 7.64%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 13, 2025 Q3 2025 |
393,755
shares
|
$27.6 Million
0.03% of portfolio
|
Q3 2025
Added 1.19%
|
|
|
Handelsbanken Fonder Ab
|
Nov 12, 2025 Q3 2025 |
388,369
shares
|
$27.2 Million
0.09% of portfolio
|
Q3 2025
Added 45.97%
|
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
Nov 13, 2025 Q3 2025 |
383,557
shares
|
$26.9 Million
0.68% of portfolio
|
Q3 2025
Reduced 7.64%
|
|
|
Retirement Systems Of Alabama
|
Oct 31, 2025 Q3 2025 |
371,195
shares
|
$26 Million
0.09% of portfolio
|
Q3 2025
Reduced 2.41%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 06, 2025 Q3 2025 |
364,162
shares
|
$25.5 Million
0.02% of portfolio
|
Q3 2025
Reduced 4.58%
|
|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
357,948
shares
|
$25.1 Million
0.03% of portfolio
|
Q3 2025
Added 46.08%
|
|
|
Cerity Partners LLC
New York, NY |
Oct 22, 2025 Q3 2025 |
348,297
shares
|
$24.4 Million
0.04% of portfolio
|
Q3 2025
Added 6.87%
|
|
|
Mizuho Markets Americas LLC
|
Oct 29, 2025 Q3 2025 |
342,147
shares
|
$24 Million
0.44% of portfolio
|
Q3 2025
Reduced 13.89%
|
|
|
Met Life Investment Management, LLC
Whippany, NJ |
Nov 13, 2025 Q3 2025 |
341,669
shares
|
$23.9 Million
0.12% of portfolio
|
Q3 2025
Reduced 14.35%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 13, 2025 Q3 2025 |
334,419
shares
|
$23.4 Million
0.01% of portfolio
|
Q3 2025
Reduced 0.93%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2025 Q3 2025 |
326,967
shares
|
$22.9 Million
0.01% of portfolio
|
Q3 2025
Reduced 34.12%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2025 Q3 2025 |
312,208
shares
|
$21.9 Million
0.01% of portfolio
|
Q3 2025
Added 89.13%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
308,223
shares
|
$21.6 Million
0.0% of portfolio
|
Q3 2025
Added 4.29%
|
|